U.S. market Open. Closes in 3 hours 56 minutes

ALT | Altimmune, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
Revenue426.00K-68.00K4.41M8.19M5.80M10.33M10.74M5.23M10.64M10.19M17.91M25.18M24.27M20.99M27.55M32.91M14.64M1.85M586.07K
Cost of Revenue477.00K68.00K551.30K33.51M17.07MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A115.00K
Gross Profit-51.00K-136.00K3.86M-25.32M-11.26M10.33MN/AN/A10.64M10.19M17.91M25.18M24.27M20.99M27.55M32.91M14.64M1.85M471.07K
Operating Expenses83.46M87.67M89.95M62.98M26.27M28.22M26.86M16.49M11.50M20.38M28.75M31.44M35.99M44.55M53.52M52.02M31.15M644.38K145.78K
Selling, General & Admin18.14M17.13M15.41M13.21M8.50M9.77M8.46M11.52M6.22M10.91M13.28M11.63M14.31M18.02M22.43M19.40M13.88M491.09K145.78K
Research & Development65.32M70.54M74.54M49.77M17.77M18.46M18.41M4.84M5.13M9.32M15.29M19.51M21.22M20.88M30.22M31.81M16.56MN/AN/A
Other Operating Expenses166.00K-32.00K-373.87K24.15K15.14K277.89KN/A143.44K141.60K149.96K182.49K303.92K461.07K5.66M872.30K813.89K705.37K153.28KN/A
Operating Income-83.51M-87.74M-96.91M-54.80M-21.46M-42.83M-52.05M-11.26M-856.64K-10.19M-10.84M-6.27M-11.73M-23.55M-25.97M-19.11M-16.50M1.20M325.30K
Other Expenses / Income-4.94M2.83M-176.78K337.24K886.30K-27.36M-18.51K216.29M-2.52M297.66K-817.40K1.54M7.97M-5.37M-3.74M-15.95M3.92MN/AN/A
Before Tax Income-88.45M-84.91M-97.09M-54.46M-20.58M-45.32M-52.06M205.02M-3.38M-9.89M-11.66M-4.72MN/AN/AN/AN/AN/A1.20M325.30K
Income Tax Expenses309.11K-197.00K-919.51K-5.42M-58.50K-6.15M-5.64M11.17M61.75K61.75K61.75K195.53KN/AN/AN/AN/AN/A187.00K48.00K
Net Income-88.45M-84.71M-96.17M-49.04M-20.52M-39.17M-46.43M193.85M-3.44M-9.96M-11.72M-4.92M-3.80M-34.85M-32.28M-36.42M-13.59M1.02M277.30K
Interest Expenses35.00K8.00K5.66K9.42K2.24K297.09K162.14KN/AN/AN/A369.28K342.56K54.57K5.94M2.84M2.57M2.12MN/AN/A
Basic Shares Outstanding53.25M46.93M41.28M25.64M13.12M2.80M426.83K217.69K213.28K191.78K168.86K161.07K157.77K107.70K91.92K76.48K31.48K38.83K26.23K
Diluted Shares Outstanding53.25M46.93M41.28M25.64M13.12M2.80M426.83K218.86K213.28K191.78K168.86K161.07K157.77K107.70K91.92K76.48K31.48K45.45K27.74K
EBITDA-83.03M-84.90M-85.72M-54.15M-19.22M-17.09M-51.76M205.17M-3.24M-9.74M-11.10M-4.08M-3.28M-27.89M-28.57M-33.03M-10.81M1.20M325.30K
EBITDA Margin-19,491.31%124,855.88%-1,943.50%-661.62%-331.28%-165.39%-482.04%3,922.74%-30.42%-95.62%-61.99%-16.20%-13.52%-132.86%-103.70%-100.35%-73.82%65.13%55.50%
EBIT-88.10M-84.90M-97.09M-54.45M-20.58M-45.02M-51.90M205.02M-3.38M-9.89M-11.29M-4.38M-3.74M-28.91M-29.44M-33.84M-11.46M1.20M325.30K
EBIT Margin-20,681.43%124,855.88%-2,201.30%-665.26%-354.68%-435.81%-483.33%3,920.00%-31.76%-97.09%-63.01%-17.41%-15.42%-137.72%-106.87%-102.83%-78.29%65.13%55.50%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙